SLC5A2 and type 2 diabetes mellitus: Sodium-glucose co-transporters 2 (SGLT2) inhibitors are an important class of medications that have become increasingly used not only in the management of type 2 diabetes but also for cardioprotection and slowing the progression of renal dysfunction.